China Transcatheter Heart Valves Market Outlook to 2033 - Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Implantation (TMVI) and Others

Description

GlobalData's "China Transcatheter Heart Valves Market Outlook to 2033" is a comprehensive databook report, covering key market data on the China Transcatheter Heart Valves market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Implantation (TMVI) and Others.

The China Transcatheter Heart Valves Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Transcatheter Heart Valves Market.
Global corporate-level profiles of key companies operating within the China Transcatheter Heart Valves Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

China Transcatheter Heart Valves is segmented as follows -

Transcatheter Aortic Valve Replacement (TAVR),
Transcatheter Mitral Valve Repair (TMVR)
Transcatheter Pulmonary Valve Replacement (TPVR)
Transcatheter Mitral Valve Implantation (TMVI)

Reasons to Buy

China Transcatheter Heart Valves Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME0300CCDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Transcatheter Heart Valves Segmentation
2.3 Definitions of Markets Covered in the Report

3 Transcatheter Heart Valves Market, China

3.1 Transcatheter Heart Valves Market, China, Revenue ($m), 2018-2033
3.2 Transcatheter Heart Valves Market, China, Volume (Units), 2018-2033
3.3 Transcatheter Heart Valves Market, China, Average Price ($) , 2018-2033
3.4 Transcatheter Heart Valves Market, China, Distribution Share by Revenue ($m), 2023
3.5 Transcatheter Heart Valves Market, China, Company Share by Revenue ($m), 2023

4 Overview of Key Companies in China, Transcatheter Heart Valves Market

4.1 Edwards Lifesciences Corp
- 4.1.1 Company Overview
4.2 Medtronic Plc
- 4.2.1 Company Overview
4.3 Abbott Laboratories
- 4.3.1 Company Overview
4.4 Boston Scientific Corp
- 4.4.1 Company Overview

5 Transcatheter Heart Valves Market Pipeline Products

6 Financial Deals Landscape

6.1 Acquisition
- 6.1.1 Guo Yanchao to Acquire 80% Stake in Sino Medical Sciences for USD27.94 Million
6.2 Debt Offerings
- 6.2.1 MicroPort Scientific to Raise USD220 Million in Public Offering of 5.75% Convertible Bonds Due 2028
6.3 Venture Financing
- 6.3.1 Juxin Medical Technology (Shenzhen) Secures USD13.78 Million in Series B Financing

7 Recent Developments

7.1 Corporate Communications
- 7.1.1 Feb 07, 2024: Venus Medtech-B Passing Away of an Independent Non-executive Director and Continued Suspension of Trading
- 7.1.2 Nov 10, 2023: Microport Appointment of Director
- 7.1.3 Nov 02, 2023: Venus Medtech Hangzhou Announces Resignation & Appointment of Supervisor; and Director Appointment
- 7.1.4 Sep 22, 2023: Venus Medtech Hangzhou Announces Appointment of Joint Chief Executive Officer
7.2 Financial Announcements
- 7.2.1 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report
- 7.2.2 Aug 31, 2023: Venus Medtech Hangzhou Announces Interim Results for the Six Months Ended June 30, 2023
7.3 Product News
- 7.3.1 Nov 18, 2023: Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

8 Appendix

8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Distribution Share Analysis
- 8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer